AI
Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Narrativa Raises An Additional $1.3M To Help Pharma Companies Accelerate The Fda Drug Approval Process Through Artificial Intelligence Natural Language Generation
Narrativa Raises An Additional $1.3M To Help Pharma Companies Accelerate The Fda Drug Approval Process Through Artificial Intelligence Natural Language Generation
05/18/21, 1:28 PM
Location
los angeles
Money raised
$1.3 million
Round Type
seed
Narrativa, which has built an artificial intelligence (AI) medical writing platform to help pharmaceutical companies accelerate the drug approval process and lower the overall cost of compliance, recently closed its $1.3 million financing round.
Company Info
Location
los angeles, california, united states
Additional Info
Founded in 2015, Narrativa was created from the belief that technology can be used to transform the world in a positive way. Recognized by Samsung as one of the most important companies in the NLG field, Narrativa supports businesses that want to grow by anticipating trends and transforming data into human language in real time. Through its artificial intelligence system and experience in machine learning, Narrativa produces automated content in diverse fields, including finance, pharmaceuticals, insurance, media, and gaming among others. Visit www.Narrativa.com to learn more.
Contact:Matthew RectorNarrativa, USA[email protected] Direct: (323) 487-2901
Sofia SanchezNarrativa, International[email protected]
SOURCE Narrativa
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.